NOVARTIS N (NOVN.VX)


Swiss - Swiss Delayed Price. Currency in CHF
79.15-0.10 (-0.13%)
At close: 11:31 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open79.40
Prev Close79.25
Bid78.50 x 373700
Ask79.40 x 1281100
Day's Range78.60 - 79.40
52wk Range76.10 - 79.80
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
BetaN/A
Volume4,589,639
Avg Vol (3m)4,377,327
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Financial Times5 days ago

    [$$] Opinions split on Witty regime at GSK

    Sir Andrew Witty will hand over to Emma Walmsley next March after almost nine years as chief executive of GlaxoSmithKline and three decades at the company with opinions sharply divided over his legacy. ...

  • Financial Times5 days ago

    [$$] Incoming GSK chief faces challenge to maintain momentum

    Running GlaxoSmithKline would be one of the biggest jobs in UK business at any time. For Emma Walmsley, appointed on Tuesday to succeed Sir Andrew Witty as chief executive, the challenge will be especially ...

  • Financial Times6 days ago

    [$$] GSK: Walmsley must focus coolly on drug costs

    Because she's worth it? Emma Walmsley, a former L'Oréal executive, has won the contest to become chief executive of GlaxoSmithKline. A businesswoman with a background in cosmetics will lead the UK's premier ...